Investors Capital Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Investors Capital Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$524K	Buy	6,114 +315	+5%	+$28.3K	0.1%	264
2016 Q1	$504K	Sell	5,799 -3,255	-36%	-$291K	0.1%	262
2015 Q4	$1.02M	Sell	9,054 -471	-5%	-$51.1K	0.2%	147
2015 Q3	$963K	Sell	9,525 -4,767	-33%	-$572K	0.19%	145
2015 Q2	$1.76M	Buy	14,292 +1,665	+13%	+$199K	0.32%	65
2015 Q1	$1.45M	Buy	12,627 +3,036	+32%	+$335K	0.27%	91
2014 Q4	$969K	Buy	9,591 +1,929	+25%	+$187K	0.18%	156
2014 Q3	$698K	Buy	7,662 +4,206	+122%	+$369K	0.14%	212
2014 Q2	$296K	Buy	3,456 +258	+8%	+$20.3K	0.05%	474
2014 Q1	$252K	Sell	3,198 -6,483	-67%	-$540K	0.05%	453
2013 Q4	$732K	Buy	9,681 +627	+7%	+$44.5K	0.17%	174
2013 Q3	$632K	Buy	9,054 +1,959	+28%	+$128K	0.16%	190
2013 Q2	$411K	Buy	+7,095	New	+$410K	0.13%	233

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Investors Capital Advisory Services's IBB Position: Q2 2016 in Review

Investors Capital Advisory Services increased its iShares Biotechnology ETF (IBB) stake by 5.4% in Q2 2016, buying an estimated $28.3K and bringing the position to 6,114 shares worth $524K. The position accounts for 0.1% of the portfolio, ranked #264.

Investors Capital Advisory Services first reported a position in IBB in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.76M in Q2 2015. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Investors Capital Advisory Services held 6,114 shares of iShares Biotechnology ETF worth $524K as of Q2 2016.
Investors Capital Advisory Services bought 315 iShares Biotechnology ETF shares in Q2 2016, an estimated $28.3K.
iShares Biotechnology ETF made up 0.1% of Investors Capital Advisory Services's portfolio in Q2 2016, its #264 holding.
Investors Capital Advisory Services first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 13 quarters since.
Investors Capital Advisory Services's iShares Biotechnology ETF position peaked at $1.76M in Q2 2015.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.